New Laboratory Tests and Services
MyGenVar Rapid Acute Leukemia Gene Panel, Next Generation Sequencing (RAMLGP, LAB6020) – New (In-House) test
- Indication: Rapid evaluation of acute myeloid leukemia (AML) at the time of diagnosis or possibly at relapsed/refractory disease to help guide classification and possible therapeutic approaches.
- Somatic gene mutations in ABL1, CBFB, CREBBP, ETV6, FLT3, IDH1, IDH2, KMT2A, MECOM, NPM1, NUP214, RARA RUNX1 and TP53.
- Preferred sample type: bone marrow (Bone Marrow Anatomical Pathology case); restricted to lab order only/pathologist
- Turn-around-time (TAT): 3-5 workdays.
- All RAMLGP’s will be reflexed to the MyGenVar Hematology Gene Panel, NGS for a comprehensive mutation analysis.
If you have any questions, please contact Lab Client Services at 800-695-6491 and ask to speak with your Customer Support Specialist.